Acrivon Therapeutics (ACRV) Payables (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Payables of $861,000 for Q2 2026, down 26.0% from $1.16 million a year earlier and down 25.9% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics posted Payables of $2.28 million, up 200.4% from FY2024.
- Payables has a four-year compound annual growth rate of 24.0% (FY2021 to FY2025).
- By year, Payables came in at $758,000 in FY2024 (-85.0%), $5.05 million in FY2023 (+458.4%), $904,000 in FY2022 (-6.2%) and $964,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Payables since Q4 2024.
- Year over year, Payables gained in three of the last eight quarters, with growth averaging 7.4%.
- The high point for year-over-year Payables in five years was Q4 2023 (growth of 458.4%); the low point was Q4 2024 (a decline of 85.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.16 million (Q1 2026), $2.28 million (Q4 2025) and $996,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Acrivon Therapeutics | 88.27 Mn | 88.27 Mn | - | 861,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 861,000.00 |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 996,000.00 |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 758,000.00 |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 904,000.00 |
| Sep 30, 2022 | 1.98 Mn |
| Dec 31, 2021 | 964,000.00 |
API Access
Acrivon Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();